Items 1 to 20 of 77 total

per page
Page:
  1. 1
  2. 2
  3. 3
  4. 4

Set Descending Direction
    Cat. No. Name CAS No. Description
    KI3871 (-)-Blebbistcitin 674289-55-5 ....
    KI1243 A966492 934162-61-5 A-966492 is a potent poly(ADP-Ribose) polymerase (PARP) inhibitor....
    KI0821 ABR-215050 254964-60-8 ABR-215050 is a quinoline-3-carboxamide anti-angiogenic agent....
    KI0583 ACY-1215 1316214-52-4 ACY-1215 is a histone deacetylase (HDAC) 6-selective inhibitor....
    KI0180 AG-014699 459868-92-9 AG-014699 is a potent inhibitor of Poly (ADP-ribose) polymerase (PARP) with Ki values of 1.4 and 0.17 nM for PARP-1 and PARP-2, respectively....
    KI3345 AG14361 328543-09-5 AG14361 is a potent PARP1 inhibitor with Ki of <5 nM....
    KI0634 Apicidin 183506-66-3 Apicidin is a potent histone deacetylase (HDAC) inhibitor....
    KI0401 AZD1152-HQPA 722544-51-6 AZD1152-HQPA is a specific inhibitor of the enzymatic activity of Aurora kinase....
    KI0269 AZD1480 935666-88-9 AZD1480 is a potent ATP competitive inhibitor of JAK2 kinase, with an inhibition constant (Ki) of 0.26 nM....
    KI1184 AZD2281 763113-22-0 AZD2281 is a poly ADP-ribose polymerase (PARP) inhibitor....
    KI1494 AZD2461 1174043-16-3 AZD2461 is a novel PARP (poly (ADP-ribose) polymerase) inhibitor....
    KI0028 Belinostat 414864-00-9 Belinostat is a novel hydroxamate-type inhibitor of histone deacetylase activity....
    KI3870 BIO 667463-62-9 ....
    KI1250 BIX-01294 935693-62-2 BIX-01294 is a specific G9a histone methyltransferase inhibitor....
    KI1259 BSI-201 160003-66-7 BSI-201 is an irreversible inhibitor of PARP1....
    KI3872 Canertinib dihydrochloride 289499-45-2 ....
    KI0481 CCT137690 1095382-05-0 CCT137690 is a potent and selective inhibitor of Aurora kinases....
    KI3886 CEP18770 847499-27-8 ....
    KI0112 CHR-3996 1235859-13-8 CHR-3996 is a class I selective orally active histone deacetylase (HDAC) inhibitor with an IC50 of 8 nM....
    KI3681 CI994 112522-64-2 CI-994 (Tacedinaline) is an anti-cancer drug which inhibits HDAC1 with IC50 of 0.57 ?M and causes G1 cell cycle arrest, and CI-994 is in Phase III clinical trial in patients with Lung Cancer [1]....

Items 1 to 20 of 77 total

per page
Page:
  1. 1
  2. 2
  3. 3
  4. 4

Set Descending Direction